Journals / Erciyes Tıp Dergisi / 2008 / Cilt: 30 - Sayı: 1

Phacoemulsification surgery in patients with cataract formation after intravitreal ınjection of triamcinolone acetonide

İntravitreal triamsinolon asetonid enjeksiyonu sonrası katarakt gelişen olgularda fakoemülsifikasyon cerrahisi

Pages
14–18
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Seven eyes required Nd:YAG laser therapy due to posterior capsule opasification after a mean follow-up time of 8.5 months.Conclusion: There were no additional complications secondary to IVTA injection during or after phacoemulsification surgery in patients with cataract formation following IVTA injection.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: To evaluate the results and complications of phacoemulsification surgery due to various factors in patients with cataract formation after intravitreal injection of triamcinolone acetonide (IVTA).
📊
Key Findings & Data:Materials and Methods: Forty-five eyes of 32 patients with cataract formation that had developed after one or multiple IVTA injections were included in the study.
💡
Conclusion & Impact:Seven eyes required Nd:YAG laser therapy due to posterior capsule opasification after a mean follow-up time of 8.5 months.Conclusion: There were no additional complications secondary to IVTA injection during or after phacoemulsification surgery in patients with cataract formation following IVTA injection.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Purpose: To evaluate the results and complications of phacoemulsification surgery due to various factors in patients with cataract formation after intravitreal injection of triamcinolone acetonide (IVTA). Materials and Methods: Forty-five eyes of 32 patients with cataract formation that had developed after one or multiple IVTA injections were included in the study. Among these patients, 28 eyes had diabetic macular edema, 7 eyes had branch retinal vein occlusion, 2 eyes had central retinal vein occlusion, 4 eyes had choroidal neovascular membrane due to age-related macular degeneration, 2 eyes had uveitic cystoid macular edema and 2 eyes had posterior uveitis. The mean age of the patients was 52.4±11.0 years, and all patients underwent standard phacoemulsification surgery with foldable intraocular lens implantation.Results: Minimal hemorrhage developed during surgery in 2 patients with diabetic retinopathy. After anterior chamber lavage, there was no hemorrhage after surgery and during the following days. Postoperatively, transient intraocular pressure elevation treated with topical antiglaucomatous medication was observed in 5 eyes. Seven eyes required Nd:YAG laser therapy due to posterior capsule opasification after a mean follow-up time of 8.5 months.Conclusion: There were no additional complications secondary to IVTA injection during or after phacoemulsification surgery in patients with cataract formation following IVTA injection.

Özet

Amaç: Değişik nedenlerle intravitreal triamsinolon asetonid (IVTA) enjeksiyonu uygulaması sonrası katarakt gelişen olgularda fakoemülsifikasyon cerrahisi sonuçları ve komplikasyonlarının değerlendirilmesi. Gereç ve Yöntemler: Bir veya birden fazla IVTA enjeksiyonu uygulaması sonrası katarakt gelişen 32 hastanın 45 gözü çalışma kapsamına alındı. Bu olguların 28 gözünde diabetik makula ödemi, 7'sinde ven dal tıkanıklığı, 2'inde ven kök tıkanıklığı, 4'ünde yaşa bağlı makula dejeneresansına sekonder koroidal neovasküler membran, 2'inde üveitik kistoid makula ödemi, ikisinde ise posterior üveit mevcut idi. Olguların yaş ortalaması: 52.4±11.0 yıl olup tümüne standart fakoemülsifikasyon cerrahisi ve katlanabilir intraoküler lens implantasyonu uygulandı.Bulgular: Cerrahi esnasında diabetik retinopatisi olan iki olguda minimal hemoraji gelişti ve ön kamara lavajı sonrası cerrahi sonunda ve ertesi günlerde hemoraji gözlenmedi. Postoperatif 5 olguda topikal antiglokomatöz medikasyon ile kontrol altına alınabilen geçici göziçi basıncı yükselmesi gözlendi. Ortalama 8.5 aylık takip süresi sonunda 7 olguda Nd:YAG laser gerektiren arka kapsül kesafeti gözlendi.Sonuç: İVTA enjeksiyonu sonrası katarakt gelişen gözlerde fakoemülsifikasyon cerrahisi esnasında veya sonrasında IVTA enjeksiyonuna sekonder ek komplikasyonlar ortaya çıkmamaktadır.

🔖

Cite This Article

ERKILIÇ, K., AKSU, R., AYHAN, E., ÖZKIRIŞ, A., İLHAN, Ö. (2022). Phacoemulsification surgery in patients with cataract formation after intravitreal ınjection of triamcinolone acetonide. Erciyes Tıp Dergisi, Cilt: 30 - Sayı: 1, 14–18. https://ajindex.com/articles/502653

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Ozkiris A, Evereklioglu C, Erkilic K, Dogan H: Intravitreal triamcinolone acetonide for treatment of persistent macular edema in branch retinal vein occlusion. Eye 2006;20:13-7
  2. Ozkiris A, Evereklioglu C, Oner A, Erkilic K: Pattern electroretinogram for monitoring the efficacy of intravitreal triamcinolone injection in diabetic macular edema. Doc Ophthalmol 2004;109:139-45
  3. Ozkiris A, Evereklioglu C, Erkilic K, Ilhan O: The efficacy of intravitreal triamcinolone acetonide on macular edema in branch retinal vein occlusion. Eur J Ophthalmol 2005;15:96-101
  4. Ozkiris A, Evereklioglu C, Erkilic K, Tamcelik N, Mirza E: Intravitreal triamcinolone acetonide injection as primary treatment for diabetic macular edema. Eur J Ophthalmol 2004;14:543-549
  5. Gillies MC, Simpson JM, Luo W, Penfold P, Hunyor AB, Chua W, Mitchell P, Billson F: A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration: one-year results. Arch Ophthalmol 2003;121:667-673
  6. Karacorlu M, Ozdemir H, Karacorlu S: Intravitreal triamcinolone acetonide for the treatment of chronic pseudophakic cystoid macular oedema. Acta Ophthalmol Scand 2003;81:648-52
  7. Jonas JB, Hayler JK, Sofker A, Panda-Jonas S: Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative diabetic retinopathy. Am J Ophthalmol 2001;131:468-471
  8. Jonas JB, Kreissig I, Sofker A, Degenring RF: Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthalmol 2003;121:57-61. 9.Ip MS, Kumar KS. Intravitreous triamcinolone acetonide as treatment for macular edema from central retinal vein occlusion. Arch Ophthalmol 2002;120:1217-19
  9. Martidis A, Duker JS, Greenberg PB, Rogers AH, Puliafito CA, Reichel E, Baumal C: Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 2002;4:920-927
  10. Jonas JB, Kreissig I, Degenring RF: Intravitreal triamcinolone acetonide as treatment of ischemic ophthalmopathy. Eur J Ophthalmol 2003;13:575-6
  11. Martinez JA: Intravitreal triamcinolone acetonide for bilateral acquired parafoveal telangiectasis. Arch Ophthalmol 2003;121:1658-9
  12. Rodriguez ML, Juarez CP, Luna JDÊ: Intravitreal triamcinolone acetonide injection in blind painful eyes. Intraocular steroids as a treatment for blind painful red eyes. Eur J Ophthalmol 2003;13:292-7
  13. Jonas JB, Hayler JK, Panda-Jonas S: Intravitreal injection of crystalline cortisone as treatmen